Coffee and caffeine intake and risk of ovarian cancer: a systematic review and meta-analysis
Shafiei F, Salari-Moghaddam A, Milajerdi A, Larijani B, Esmaillzadeh A
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 25 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2019-03-01 · Int J Gynecol Cancer · vol. 29 · número 3 · págs. 579–584
- Editorial
- BMJ
- Citado
- 30 citas · más que el 66% de estudios similares · 0.8× el promedio de su campo
- Referencias
- 40 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Coffee research and impacts · Nutritional Studies and Diet · Cancer Risks and Factors
- Palabras clave
- coffee consumption, caffeine consumption, decaffeinated coffee, caffeinated coffee, ovarian cancer risk, dietary factors, cancer prevention
- MeSH
- humans, ovarian neoplasms, caffeine, risk, case-control studies, coffee, female, carcinoma, ovarian epithelial
5 autores
- Fateme Shafiei🇮🇷Tehran University of Medical Sciences
- Asma Salari-Moghaddam🇮🇷Tehran University of Medical Sciences
- Alireza Milajerdi🇮🇷Tehran University of Medical Sciences
- Bagher A. Larijani🇮🇷Endocrinology and Metabolism Clinical Sciences Institute; Tehran University of Medical Sciences
- Ahmad Esmaillzadeh🇮🇷 · autor de correspondenciaIsfahan University of Medical Sciences; Obesity and Eating Habits Research Center; Endocrinology and Metabolism Molecular-Cellular Sciences Institute; Tehran University of Medical Sciences
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Results from earlier publications on the association of coffee and caffeine and risk of ovarian cancer are inconsistent.
Objective
To evaluate the link between coffee, caffeine, caffeinated coffee, and decaffeinated coffee consumption and risk of ovarian cancer.
Methods
We searched PubMed/Medline, ISI Web of Science, Scopus, and Google Scholar to identify relevant publications up to April 2018. All case-control studies that considered coffee, caffeine, caffeinated coffee, or decaffeinated coffee as the exposure variables and ovarian cancer as the main outcome variable or as one of the outcomes were included in the systematic review. Publications in which odds ratios (ORs) or rate or risk ratios (RRs) and 95% confidence intervals (CIs) were reported, were included in the meta-analysis.
Results
A total of 22 case-control studies were included in the systematic review, and 20 studies in the meta-analysis. Overall, 40 140 participants, including 8568 patients with ovarian cancer, aged ≥ 17 years were included. Combining 21 effect sizes from 18 studies, no significant association was observed between total coffee intake and risk of ovarian cancer (OR=1.09; 95% CI 0.94 to 1.26). There was no significant association between total caffeine intake and ovarian cancer risk (OR=0.89; 95% CI 0.55 to 1.45). In addition, caffeinated coffee intake was not significantly associated with ovarian cancer (OR=1.05; 95% CI 0.87 to 1.28). However, combining effect sizes from five studies, we found an inverse significant association between decaffeinated coffee intake and risk of ovarian cancer (OR=0.72; 95% CI 0.58 to 0.90).
Conclusions
Our findings indicated an inverse association between decaffeinated coffee consumption and risk of ovarian cancer. No significant association was found between coffee, caffeine or caffeinated coffee intake and risk of ovarian cancer.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.